1
|
Oliveira-Paula GH, Liu S, Maira A, Ressa G, Ferreira GC, Quintar A, Jayakumar S, Almonte V, Parikh D, Valenta T, Basler K, Hla T, Riascos-Bernal DF, Sibinga NES. The β-catenin C terminus links Wnt and sphingosine-1-phosphate signaling pathways to promote vascular remodeling and atherosclerosis. Sci Adv 2024; 10:eadg9278. [PMID: 38478616 PMCID: PMC10936954 DOI: 10.1126/sciadv.adg9278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Accepted: 02/07/2024] [Indexed: 03/17/2024]
Abstract
Canonical Wnt and sphingosine-1-phosphate (S1P) signaling pathways are highly conserved systems that contribute to normal vertebrate development, with key consequences for immune, nervous, and cardiovascular system function; despite these functional overlaps, little is known about Wnt/β-catenin-S1P cross-talk. In the vascular system, both Wnt/β-catenin and S1P signals affect vessel maturation, stability, and barrier function, but information regarding their potential coordination is scant. We report an instance of functional interaction between the two pathways, including evidence that S1P receptor 1 (S1PR1) is a transcriptional target of β-catenin. By studying vascular smooth muscle cells and arterial injury response, we find a specific requirement for the β-catenin carboxyl terminus, which acts to induce S1PR1, and show that this interaction is essential for vascular remodeling. We also report that pharmacological inhibition of the β-catenin carboxyl terminus reduces S1PR1 expression, neointima formation, and atherosclerosis. These findings provide mechanistic understanding of how Wnt/β-catenin and S1P systems collaborate during vascular remodeling and inform strategies for therapeutic manipulation.
Collapse
Affiliation(s)
- Gustavo H. Oliveira-Paula
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Sophia Liu
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Alishba Maira
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Gaia Ressa
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Graziele C. Ferreira
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
- Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil
| | - Amado Quintar
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Smitha Jayakumar
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Vanessa Almonte
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Dippal Parikh
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Tomas Valenta
- Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland
| | - Konrad Basler
- Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland
| | - Timothy Hla
- Vascular Biology Program, Boston Children's Hospital, Department of Surgery, Harvard Medical School, Boston, MA, USA
| | - Dario F. Riascos-Bernal
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Nicholas E. S. Sibinga
- Department of Medicine (Cardiology Division), Department of Developmental and Molecular Biology, and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY, USA
| |
Collapse
|
2
|
Riascos-Bernal DF, Ressa G, Korrapati A, Sibinga NES. The FAT1 Cadherin Drives Vascular Smooth Muscle Cell Migration. Cells 2023; 12:1621. [PMID: 37371091 PMCID: PMC10297709 DOI: 10.3390/cells12121621] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2023] [Revised: 06/11/2023] [Accepted: 06/12/2023] [Indexed: 06/29/2023] Open
Abstract
Vascular smooth muscle cells (VSMCs) are normally quiescent and non-migratory, regulating the contraction and relaxation of blood vessels to control the vascular tone. In response to arterial injury, these cells become active; they proliferate, secrete matrix proteins, and migrate, and thereby contribute importantly to the progression of several cardiovascular diseases. VSMC migration specifically supports atherosclerosis, restenosis after catheter-based intervention, transplant vasculopathy, and vascular remodeling during the formation of aneurysms. The atypical cadherin FAT1 is expressed robustly in activated VSMCs and promotes their migration. A positive role of FAT1 in the migration of other cell types, including neurons, fibroblasts, podocytes, and astrocyte progenitors, has also been described. In cancer biology, however, the effect of FAT1 on migration depends on the cancer type or context, as FAT1 either suppresses or enhances cancer cell migration and invasion. With this review, we describe what is known about FAT1's effects on cell migration as well as the factors that influence FAT1-dependent migration. In VSMCs, these factors include angiotensin II, which activates FAT1 expression and cell migration, and proteins of the Atrophin family: Atrophin-1 and the short isoform of Atrophin-2, which promote VSMC migration, and the long isoform of Atrophin-2, which exerts negative effects on FAT1-dependent VSMC migration.
Collapse
Affiliation(s)
- Dario F. Riascos-Bernal
- Department of Medicine (Cardiology) and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY 10461, USA; (G.R.); (A.K.)
- Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
| | - Gaia Ressa
- Department of Medicine (Cardiology) and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY 10461, USA; (G.R.); (A.K.)
| | - Anish Korrapati
- Department of Medicine (Cardiology) and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY 10461, USA; (G.R.); (A.K.)
| | - Nicholas E. S. Sibinga
- Department of Medicine (Cardiology) and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY 10461, USA; (G.R.); (A.K.)
- Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
| |
Collapse
|
3
|
Scotti A, Leone PP, Sturla M, Curio J, Spring AM, Ressa G, Ludwig S, Sugiura T, Assafin M, Granada JF, Chau M, Doolittle J, Latib A. Prophylactic intra-aortic balloon pump in transfemoral transcatheter aortic valve implantation. EUROINTERVENTION 2023; 19:e188-e190. [PMID: 36846884 PMCID: PMC10240718 DOI: 10.4244/eij-d-22-00798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2022] [Accepted: 01/26/2023] [Indexed: 03/01/2023]
Affiliation(s)
- Andrea Scotti
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
- Cardiovascular Research Foundation, New York, NY, USA
| | - Pier Pasquale Leone
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| | - Matteo Sturla
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| | - Jonathan Curio
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| | - Alexander M Spring
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| | - Gaia Ressa
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| | - Sebastian Ludwig
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
- Cardiovascular Research Foundation, New York, NY, USA
| | - Tadahisa Sugiura
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| | - Manaf Assafin
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| | - Juan F Granada
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
- Cardiovascular Research Foundation, New York, NY, USA
| | - Mei Chau
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| | - James Doolittle
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| | - Azeem Latib
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA
| |
Collapse
|
4
|
Scotti A, Leone PP, Sturla M, Curio J, Spring AM, Ressa G, Ludwig S, Sugiura T, Assafin M, Granada JF, Chau M, Doolittle J, Latib A. CRT-700.48 Prophylactic Intra-Aortic Balloon Pump in Transfemoral Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv 2023. [DOI: 10.1016/j.jcin.2023.01.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
|
5
|
Oliveira de Paula GH, Parikh D, Ressa G, Almonte V, Valenta T, Basler K, Riascos‐Bernal D, Sibinga N. β‐catenin C‐terminal Domain/Sphingosine‐1‐Phosphate Receptor 1 Axis is a Potential Therapeutic Target in Vascular Remodeling. FASEB J 2022. [DOI: 10.1096/fasebj.2022.36.s1.r5593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Dippal Parikh
- Medicine, Division of CardiologyAlbert Einstein College of MedicineNew YorkNY
| | - Gaia Ressa
- Medicine, Division of CardiologyAlbert Einstein College of MedicineNew YorkNY
| | - Vanessa Almonte
- Medicine, Division of CardiologyAlbert Einstein College of MedicineNew YorkNY
| | | | | | | | - Nicholas Sibinga
- Medicine, Division of CardiologyAlbert Einstein College of MedicineNew YorkNY
| |
Collapse
|
6
|
Belvisi D, Pellicciari R, Fabbrini A, Costanzo M, Ressa G, Pietracupa S, De Lucia M, Modugno N, Magrinelli F, Dallocchio C, Ercoli T, Nicoletti A, Zappia M, Solla P, Bologna M, Fabbrini G, Tinazzi M, Conte A, Berardelli A, Defazio G. Relationship between risk and protective factors and clinical features of Parkinson's disease. Parkinsonism Relat Disord 2022; 98:80-85. [PMID: 35526494 DOI: 10.1016/j.parkreldis.2022.04.017] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2022] [Revised: 04/21/2022] [Accepted: 04/22/2022] [Indexed: 10/18/2022]
Abstract
BACKGROUND Non-genetic risk factors play a relevant role in Parkinson's disease (PD) development but the relationship between these factors and PD clinical features is unknown. OBJECTIVE The aim of the present multicenter study was to investigate possible relationship between risk factors and clinical motor and non-motor features in a large sample of PD patients. METHODS Six hundred ninety-four patients with PD participated. Patients underwent a clinical evaluation assessing motor symptoms and motor complications as well as non-motor symptoms severity. Information regarding pharmacological treatment was also collected. Risk and protective factors were previously identified in the present population and included coffee consumption, cigarette smoking, and physical activity as protective factors and a family history of PD, dyspepsia, exposure to toxic agents and general anesthesia as risk factors. Multiple regression models were used to investigate the relationship between risk factors and clinical variables. RESULTS Coffee consumption predicted older age at onset (B: 0.527; CI: 0.195; 0.858) and milder motor symptom severity (B: 1.383; CI: 2.646; -0.121). Non-motor symptom severity was more severe in patients with dyspepsia before PD (B: 13.601; CI 5.019; 22.182) and milder in patients who performed physical activity before PD (B: 11.355; CI: 16.443; -6.266). We found no relationship between risk factors and motor complications, motor subtype and pharmacological treatment. CONCLUSIONS Risk and protective factors of PD development may influence PD clinical features. This finding may represent the first step in the development of new preventive approaches able to delay disease onset and mitigate the extent of clinical manifestations.
Collapse
Affiliation(s)
- Daniele Belvisi
- IRCCS Neuromed, Via Atinense 18, 86077, Pozzilli, IS, Italy; Department of Human Neurosciences, Sapienza, University of Rome, Viale dell' Università, 30, 00185, Rome, Italy
| | - Roberta Pellicciari
- Department of Basic Medical Sciences, Neuroscience and Sense Organs, "Aldo Moro", University of Bari, Bari, Italy
| | - Andrea Fabbrini
- Department of Human Neurosciences, Sapienza, University of Rome, Viale dell' Università, 30, 00185, Rome, Italy
| | | | - Gaia Ressa
- Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, New York, 10461, USA
| | | | - Maria De Lucia
- IRCCS Neuromed, Via Atinense 18, 86077, Pozzilli, IS, Italy
| | - Nicola Modugno
- IRCCS Neuromed, Via Atinense 18, 86077, Pozzilli, IS, Italy
| | - Francesca Magrinelli
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy
| | - Carlo Dallocchio
- Neurology Unit, ASST Pavia-Ospedale Civile di Voghera, Voghera, Italy
| | - Tommaso Ercoli
- Department of Medical Sciences and Public Health, University of Cagliari, SS 554 bivio, Sestu, 09042, Monserrato, CA, Italy
| | - Alessandra Nicoletti
- Department G.F. Ingrassia, Neuroscience Section, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy
| | - Mario Zappia
- Department G.F. Ingrassia, Neuroscience Section, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy
| | - Paolo Solla
- Department of Medical Sciences and Public Health, University of Cagliari, SS 554 bivio, Sestu, 09042, Monserrato, CA, Italy
| | - Matteo Bologna
- IRCCS Neuromed, Via Atinense 18, 86077, Pozzilli, IS, Italy; Department of Human Neurosciences, Sapienza, University of Rome, Viale dell' Università, 30, 00185, Rome, Italy
| | - Giovanni Fabbrini
- IRCCS Neuromed, Via Atinense 18, 86077, Pozzilli, IS, Italy; Department of Human Neurosciences, Sapienza, University of Rome, Viale dell' Università, 30, 00185, Rome, Italy
| | - Michele Tinazzi
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Via Casorati 43, 37131, Verona, Italy
| | - Antonella Conte
- IRCCS Neuromed, Via Atinense 18, 86077, Pozzilli, IS, Italy; Department of Human Neurosciences, Sapienza, University of Rome, Viale dell' Università, 30, 00185, Rome, Italy
| | - Alfredo Berardelli
- IRCCS Neuromed, Via Atinense 18, 86077, Pozzilli, IS, Italy; Department of Human Neurosciences, Sapienza, University of Rome, Viale dell' Università, 30, 00185, Rome, Italy.
| | - Giovanni Defazio
- Department of Medical Sciences and Public Health, University of Cagliari, SS 554 bivio, Sestu, 09042, Monserrato, CA, Italy
| |
Collapse
|